Sequential Anti-PD1 Therapy Following Dendritic Cell Vaccination Improves Survival in a HER2 Mammary Carcinoma Model and Identifies a Critical Role for CD4 T Cells in Mediating the Response.

Front Immunol · 2019 · PMC6702967 · PMID 31475002

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a slight trendno p-value reported

There was a slight trend toward increased IFN-γ levels between the class II HER2-DC1 alone group and the combination of class II HER2-DC1 and anti-PD-1 antibody treated group in response to re-stimulation with peptides.

also in 4,078 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.